corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 19144

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Sales Through Retail Pharmacies (Twelve months to December 2010)
IMS Health 2011 Feb
http://view.respond.imshealth.com/?j=fe5815787d6405747d10&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe28167271610c7e711778&r=0


Full text:

NORTH AMERICA $243.8 billion up 3%
U.S.A. $224.5 billion up 3%
CANADA $19.3 billion up 3%

EUROPE (TOP 5) $106.1 billion up 1%
GERMANY $34.6 billion up 3%
FRANCE $27.9 billion up 0%
ITALY $15.7 billion up 0%
SPAIN $14.3 billion up 0%
UK $13.6 billion up 2%

JAPAN (including hospitals) $85.7 billion up 0%

CHINA (hospital) $32.2 billion up 23%

LATIN AMERICA (TOP 4) $35.6 billion
BRAZIL $17.5 billion up 20%
MEXICO $7.8 billion up 2%
VENEZUELA $6.2 billion up 32%
ARGENTINA $4.0 billion up 25%

AUSTRALIA/NZ $9.7 billion up 6%

The top 5 therapy classes at ATC3 level in the 12 months to December 2010 were:
1. C10A – Cholesterol & trigly. regulators Buy Forecast for USA Market
2. A2B – Antiulcerants Buy Forecast for China Market
3. N5A – Antipsychotics Buy Forecast for Italy Market
4. N6A – Antidepressants & mood stabilisers Buy Forecast for UK Market
5. C9C – Angioten-II Antag, Plain Buy Forecast for Germany Market

The top 5 products in the 12 months to December 2010 were:
1. Lipitor
2. Plavix
3. Nexium
4. Seretide
5. Crestor

The top 5 corporations in the 12 months to December 2010 were:
1. Pfizer
2. Novartis
3. AstraZeneca
4. Merck & Co
5. GlaxoSmithKline

View our full selection of Pharma Market Sales and Growth Reports in the IMS Store here: http://www.store.imshealth.com/s.nl/sc.1/category.10/.f

*Source: IMS HEALTH. Growth rates are calculated at a constant exchange rate, (i.e. at the local currency level).The unique system in Japan reduces the importance of the retail pharmacy in the distribution chain so sales for Japan include hospital data. For the USA, retail, foodstore and mail order pharmacy channels are included. In other countries sales monitored are limited to retail pharmacies only.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909